Adherence to glucose monitoring with intermittently scanned continuous glucose monitoring in patients with type 1 diabetes
- PMID: 36574148
- PMCID: PMC9988994
- DOI: 10.1007/s12020-022-03288-1
Adherence to glucose monitoring with intermittently scanned continuous glucose monitoring in patients with type 1 diabetes
Abstract
Purpose: This study aims to predict the Intermittently scanned continuous glucose monitoring (isCGM) adherence behavior of patients with Type 1 Diabetes.
Methods: Patients with Type 1 Diabetes mellitus using FreeStyle Libre™ System (FL), a isCGM device, that attended the "Insulin Infusion Pump clinic" at Centro Hospitalar de São João were enrolled and evaluated for sociodemographic and clinical characterization, beliefs and concerns about Diabetes Mellitus, as well as isCGM's perceptions. Intermittently scanned continuous glucose monitoring data were collected to characterize monitoring patterns and to measure isCGM's adherence-FL average of scans/day.
Results: Seventy-two patients with a mean of 30.36 years (sd=11.35) participate in this study. A median of 7 scans/day was performed. The adherence predictors found was Age (β = 0.191, p = 0.006), Time in target (β = 0.530, p = 0.002), isCGM Necessity (β = 2.631, p = 0.048), Body Mass Index (β = -0.549, p = 0.017) and Sex (β = -3.996; p = 0.011).
Conclusions: This study emphasizes the relevance of glucose monitoring adherence in disease control and shows that males of younger ages, presenting with higher body mass index levels, lower time in target, and reporting lower isCGM necessity are less adherent to isCGM. Therefore, these patients should be closely followed and object of personalized strategies to promote treatment adherence.
Keywords: Adherence; Illness representations; Intermittently scanned continuous glucose monitoring (isCGM); Treatment representations; Type 1 Diabetes.
© 2022. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Similar articles
-
To evaluate the use and clinical effect of intermittently scanned continuous glucose monitoring in adults with type 1 diabetes: Results of a multicentre study.Endocrinol Diabetes Nutr (Engl Ed). 2023 Apr;70(4):270-276. doi: 10.1016/j.endien.2023.03.013. Endocrinol Diabetes Nutr (Engl Ed). 2023. PMID: 37116972
-
Comparing real-time and intermittently scanned continuous glucose monitoring in adults with type 1 diabetes (ALERTT1): a 6-month, prospective, multicentre, randomised controlled trial.Lancet. 2021 Jun 12;397(10291):2275-2283. doi: 10.1016/S0140-6736(21)00789-3. Epub 2021 Jun 2. Lancet. 2021. PMID: 34089660 Clinical Trial.
-
Lower Glycated Hemoglobin with Real-Time Continuous Glucose Monitoring Than with Intermittently Scanned Continuous Glucose Monitoring After 1 Year: The CORRIDA LIFE Study.Diabetes Technol Ther. 2022 Dec;24(12):859-867. doi: 10.1089/dia.2022.0152. Epub 2022 Sep 22. Diabetes Technol Ther. 2022. PMID: 36037056 Clinical Trial.
-
Systematic Review of Randomized Controlled Trials Evaluating Glycemic Efficacy and Patient Satisfaction of Intermittent-Scanned Continuous Glucose Monitoring in Patients with Diabetes.Diabetes Technol Ther. 2020 May;22(5):337-345. doi: 10.1089/dia.2019.0345. Diabetes Technol Ther. 2020. PMID: 31859531
-
Evidence reviews for continuous glucose monitoring in children and young people with type 1 diabetes: Type 1 diabetes in children and young people: diagnosis and management: Evidence review B.London: National Institute for Health and Care Excellence (NICE); 2022 Mar. London: National Institute for Health and Care Excellence (NICE); 2022 Mar. PMID: 35816594 Free Books & Documents. Review.
Cited by
-
Validation of a predictive calculator for optimal glycemic control and time-in-tight-range following CGM sensor placement in type 1 diabetes and pancreatic diabetes: a prospective study.Endocrine. 2025 Aug 26. doi: 10.1007/s12020-025-04385-7. Online ahead of print. Endocrine. 2025. PMID: 40858920
-
Frequent Self-Monitoring Blood Glucose Correlated to Better Medication Adherence and Glycemic Control in Children with Type 1 Diabetes Mellitus.Diabetes Metab Syndr Obes. 2024 Jun 4;17:2203-2209. doi: 10.2147/DMSO.S448508. eCollection 2024. Diabetes Metab Syndr Obes. 2024. PMID: 38854446 Free PMC article.
-
Exploring the Impact of Device Sourcing on Real-World Adherence and Cost Implications of Continuous Glucose Monitoring in Patients With Diabetes: Retrospective Claims Analysis.JMIR Diabetes. 2024 Jul 22;9:e58832. doi: 10.2196/58832. JMIR Diabetes. 2024. PMID: 38804821 Free PMC article.
-
Impact of health management on medication adherence and blood pressure and blood glucose indices in elderly patients with hypertension and diabetes mellitus.Endocrine. 2025 Aug;89(2):448-455. doi: 10.1007/s12020-025-04249-0. Epub 2025 May 22. Endocrine. 2025. PMID: 40402406
-
Population characteristics, prescription patterns and glycemic control of users of flash glucose monitoring systems in Brazil: a real-world evidence study.Diabetol Metab Syndr. 2025 Feb 3;17(1):44. doi: 10.1186/s13098-025-01610-1. Diabetol Metab Syndr. 2025. PMID: 39901274 Free PMC article.
References
-
- International Diabetes Federation: IDF Diabetes Atlas. https://www.diabetesatlas.org (2021). Accessed 7 october 2022
-
- Sociedade Portuguesa de Diabetologia: Diabetes: Factos e Números – O Ano de 2016, 2017 e 2018. In. Lisboa, (2019)
-
- Sabaté, E.: In: Adherence to long-term therapies: evidence for action World Health Organization, Geneva, (2003)
-
- Kaufman, F.R. Patient Self-Management Education. In: Medical Management of Type 1 Diabetes. pp. 37–48. American Diabetes Association, Alexandria, Virginia (2012)
-
- Standards of medical care for patients with diabetes mellitus. Diabetes Care 25(1), 213–229 (2002). 10.2337/diacare.25.1.213 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical